Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Immune Checkpoint Inhibitors Market Surpasses $22 Billion in Global RevenueBy: Medtech Ventures llp Immune checkpoint inhibitors represent some of the most advanced treatments available to patients with cancer and are rapidly becoming the primary first-line treatments for patients with metastatic non-small cell lung cancer, metastatic melanoma and metastatic renal cell carcinoma. Immune Checkpoint Inhibitors – Technology and Market Forecast report offers a helicopter snapshot of current situation in this fast evolving dynamic market. The report is targeted at senior executives in the pharmaceutical, biopharmaceutical, and venture capital industries. Companies mentioned in the reports include Agenus, AnaptysBio, AstraZeneca, BeiGene, Bristol-Myers Squibb, Eli Lilly, Incyte, Innovent Biologics, Janssen (JnJ), Jiangsu Hengrui, Junshi Bioscience, MacroGenics, Merck (MSD), Merck KGaA, Novartis, Pfizer, Regeneron, Roche (Genentech) and Sanofi (Genzyme). Just released report from Medtech Ventures available at: https://www.researchandmarkets.com/ Report is also available from Amazon.com: https://www.amazon.com/ List of Tables & Figures 1. Top Five Immune Checkpoint Inhibitor Brands by Global Revenue (2019) 2. Immune System in Action 3. Checkpoint Mechanism Of Action 4. Checkpoint Inhibitors Mechanism Of Action 5. Predictive Biomarkers for Immune Checkpoint Inhibitors 6. List of FDA Approved Immune Checkpoint Inhibitors 7. Merck's Keytruda (pembrolizumab) 8. Bristol- 9. Roche's Tecentriq (Atezolizumab) 10. AstraZeneca's Imfinzi (Durvalumab) 11. Bristol- 12. Regeneron Libtayo (cemiplimab) 13. Pfizer Bavencio (Avelumab) - Global Sales Evolution (2017-2019) 14. Global Immune Checkpoint Inhibitors Market Revenue and Growth Rates (2011-2019) 15. Leading Immune Checkpoint Inhibitors Brands- Global Market Shares (2019) 16. Leading Immune Checkpoint Inhibitors Companies – Global Market Shares (2019) 17. Immune Checkpoint Inhibitors - Target Protein Segmentation – 2019 18. Immune Checkpoint Inhibitors - Geographical Segmentation – 2019 19. Immune Checkpoint Inhibitors - Clinical Trials Recruitment 20. Immune Checkpoint Inhibitors in Development or Near Commercialization 21. Immune Checkpoint Inhibitors -Clinical Trials Landscape 22. Predictive Biomarkers In Patients Treated With Immune Checkpoint Inhibitors 23. Immune Checkpoint Inhibitors - Global Market Forecast (2020 - 2025) End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|